ERBB2 c.260C>A ;(p.A87D)

Variant ID: 17-37864608-C-A

NM_004448.2(ERBB2):c.260C>A;(p.A87D)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Pan-urologic cancer genomic subtypes that transcend tissue of origin.

Nature Communications
Chen, Fengju F; Zhang, Yiqun Y; Bossé, Dominick D; Lalani, Aly-Khan A AA; Hakimi, A Ari AA; Hsieh, James J JJ; Choueiri, Toni K TK; Gibbons, Don L DL; Ittmann, Michael M; Creighton, Chad J CJ
Publication Date: 2017-08-04

Variant appearance in text: ERBB2: 260C>A; A87D
PubMed Link: 28775315
Variant Present in the following documents:
  • 41467_2017_289_MOESM7_ESM.xlsx, sheet 1
View BVdb publication page



High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.

Plos One
Anfossi, Simone S; Giordano, Antonio A; Gao, Hui H; Cohen, Evan N EN; Tin, Sanda S; Wu, Qiong Q; Garza, Raul J RJ; Debeb, Bisrat G BG; Alvarez, Ricardo H RH; Valero, Vicente V; Hortobagyi, Gabriel N GN; Calin, George A GA; Ueno, Naoto T NT; Woodward, Wendy A WA; Reuben, James M JM
Publication Date: 2014

Variant appearance in text: HER2: A87D
PubMed Link: 24416156
Variant Present in the following documents:
  • Main text
View BVdb publication page